Although such a high dose of the study drug maintained undetectable levels of dAXP and over 1100 U/L of ADA enzyme activity during hospitalization, his condition was getting worse despite multiple drug treatments of antibiotics and anti‐CMV drugs and died of pneumonia caused by CMV infection after the 16th administration. This evidence concerns the gene ADA and susceptibility to pneumonia measurement.